Northern Trust’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.68B | Sell |
3,415,610
-33,713
| -1% | -$18.3M | 0.22% | 79 |
|
|
2025
Q4 | $2B | Sell |
3,449,323
-72,382
| -2% | -$40.9M | 0.25% | 68 |
|
|
2025
Q3 | $1.71B | Sell |
3,521,705
-84,636
| -2% | -$39.4M | 0.22% | 81 |
|
|
2025
Q2 | $1.46B | Sell |
3,606,341
-276,478
| -7% | -$116M | 0.2% | 91 |
|
|
2025
Q1 | $1.93B | Sell |
3,882,819
-27,196
| -0.7% | -$14.7M | 0.29% | 56 |
|
|
2024
Q4 | $2.03B | Buy |
3,910,015
+455,004
| +13% | +$250M | 0.29% | 50 |
|
|
2024
Q3 | $2.14B | Sell |
3,455,011
-184,398
| -5% | -$109M | 0.35% | 44 |
|
|
2024
Q2 | $2.01B | Sell |
3,639,409
-28,083
| -0.8% | -$16.1M | 0.34% | 48 |
|
|
2024
Q1 | $2.13B | Sell |
3,667,492
-119,621
| -3% | -$67.1M | 0.37% | 45 |
|
|
2023
Q4 | $2.01B | Sell |
3,787,113
-142,112
| -4% | -$68.8M | 0.36% | 44 |
|
|
2023
Q3 | $1.99B | Buy |
3,929,225
+99,377
| +3% | +$53M | 0.39% | 41 |
|
|
2023
Q2 | $2B | Sell |
3,829,848
-259,221
| -6% | -$140M | 0.38% | 41 |
|
|
2023
Q1 | $2.36B | Buy |
4,089,069
+21,122
| +0.5% | +$11.9M | 0.47% | 35 |
|
|
2022
Q4 | $2.24B | Buy |
4,067,947
+109,310
| +3% | +$57.9M | 0.47% | 35 |
|
|
2022
Q3 | $2.01B | Sell |
3,958,637
-20,871
| -0.5% | -$11.7M | 0.46% | 37 |
|
|
2022
Q2 | $2.16B | Sell |
3,979,508
-199,841
| -5% | -$110M | 0.46% | 37 |
|
|
2022
Q1 | $2.47B | Sell |
4,179,349
-18,973
| -0.5% | -$10.9M | 0.43% | 36 |
|
|
2021
Q4 | $2.8B | Sell |
4,198,322
-67,711
| -2% | -$42.3M | 0.46% | 37 |
|
|
2021
Q3 | $2.44B | Buy |
4,266,033
+15,095
| +0.4% | +$8.28M | 0.43% | 42 |
|
|
2021
Q2 | $2.14B | Sell |
4,250,938
-73,816
| -2% | -$34.8M | 0.38% | 48 |
|
|
2021
Q1 | $1.97B | Sell |
4,324,754
-75,665
| -2% | -$36.1M | 0.37% | 50 |
|
|
2020
Q4 | $2.05B | Buy |
4,400,419
+880
| +0% | +$413K | 0.4% | 47 |
|
|
2020
Q3 | $1.94B | Sell |
4,399,539
-7,157
| -0.2% | -$2.96M | 0.43% | 44 |
|
|
2020
Q2 | $1.6B | Sell |
4,406,696
-6,890
| -0.2% | -$2.31M | 0.38% | 51 |
|
|
2020
Q1 | $1.25B | Sell |
4,413,586
-4,188
| -0.1% | -$1.32M | 0.36% | 55 |
|
|
2019
Q4 | $1.44B | Sell |
4,417,774
-16,454
| -0.4% | -$4.99M | 0.32% | 62 |
|
|
2019
Q3 | $1.29B | Buy |
4,434,228
+7,111
| +0.2% | +$2.04M | 0.31% | 58 |
|
|
2019
Q2 | $1.3B | Buy |
4,427,117
+2,585
| +0.1% | +$712K | 0.31% | 60 |
|
|
2019
Q1 | $1.21B | Buy |
4,424,532
+45,084
| +1% | +$11.2M | 0.3% | 66 |
|
|
2018
Q4 | $980M | Buy |
4,379,448
+157,157
| +4% | +$36.9M | 0.27% | 71 |
|
|
2018
Q3 | $1.03B | Sell |
4,222,291
-28,987
| -0.7% | -$6.67M | 0.25% | 80 |
|
|
2018
Q2 | $881M | Sell |
4,251,278
-40,207
| -0.9% | -$8.53M | 0.22% | 88 |
|
|
2018
Q1 | $886M | Sell |
4,291,485
-79,007
| -2% | -$16.6M | 0.23% | 85 |
|
|
2017
Q4 | $830M | Sell |
4,370,492
-97,671
| -2% | -$18.7M | 0.21% | 94 |
|
|
2017
Q3 | $845M | Buy |
4,468,163
+327,618
| +8% | +$59.3M | 0.22% | 92 |
|
|
2017
Q2 | $722M | Sell |
4,140,545
-106,044
| -2% | -$17.8M | 0.2% | 100 |
|
|
2017
Q1 | $652M | Buy |
4,246,589
+22,074
| +0.5% | +$3.37M | 0.19% | 110 |
|
|
2016
Q4 | $596M | Sell |
4,224,515
-107,401
| -2% | -$15.8M | 0.18% | 112 |
|
|
2016
Q3 | $689M | Buy |
4,331,916
+34,414
| +0.8% | +$5.3M | 0.21% | 93 |
|
|
2016
Q2 | $635M | Buy |
4,297,502
+52,827
| +1% | +$7.8M | 0.21% | 99 |
|
|
2016
Q1 | $598M | Sell |
4,244,675
-44,402
| -1% | -$5.95M | 0.2% | 102 |
|
|
2015
Q4 | $608M | Sell |
4,289,077
-319,132
| -7% | -$42.6M | 0.2% | 94 |
|
|
2015
Q3 | $563M | Sell |
4,608,209
-118,023
| -2% | -$15.4M | 0.19% | 103 |
|
|
2015
Q2 | $613M | Buy |
4,726,232
+2,047
| +0% | +$267K | 0.18% | 110 |
|
|
2015
Q1 | $635M | Sell |
4,724,185
-118,714
| -2% | -$15.3M | 0.19% | 106 |
|
|
2014
Q4 | $607M | Buy |
4,842,899
+7,300
| +0.2% | +$888K | 0.18% | 112 |
|
|
2014
Q3 | $588M | Sell |
4,835,599
-121,859
| -2% | -$14.8M | 0.18% | 114 |
|
|
2014
Q2 | $585M | Buy |
4,957,458
+164,787
| +3% | +$19.4M | 0.18% | 115 |
|
|
2014
Q1 | $576M | Buy |
4,792,671
+181,817
| +4% | +$21.6M | 0.18% | 112 |
|
|
2013
Q4 | $513M | Buy |
4,610,854
+10,659
| +0.2% | +$1.06M | 0.16% | 126 |
|
|
2013
Q3 | $424M | Sell |
4,600,195
-181,523
| -4% | -$16.4M | 0.15% | 133 |
|
|
2013
Q2 | $405M | Buy |
+4,781,718
| New | +$398M | 0.15% | 136 |
|
Other funds holding TMO
VCM
Northern Trust's TMO Position: Q1 2026 in Review
Northern Trust reduced its Thermo Fisher Scientific (TMO) stake by 0.98% in Q1 2026, selling an estimated $18.3M and leaving 3,415,610 shares worth $1.68B. The position accounts for 0.22% of the portfolio, ranked #79.
Northern Trust first reported a position in TMO in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.8B in Q4 2021. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.
- Northern Trust held 3,415,610 shares of Thermo Fisher Scientific worth $1.68B as of Q1 2026.
- Northern Trust sold 33,713 Thermo Fisher Scientific shares in Q1 2026, an estimated $18.3M.
- Thermo Fisher Scientific made up 0.22% of Northern Trust's portfolio in Q1 2026, its #79 holding.
- Northern Trust first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 52 quarters since.
- Northern Trust's Thermo Fisher Scientific position peaked at $2.8B in Q4 2021.
- 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.
Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.